Tag: human papillomavirus
Positive Phase II Trial Results for Tisotumab Vedotin Cervical Cancer
The phase II innovaTV 204 trial, a single-arm clinical trial also known as GCT1015-04 or GOG-3023/ENGOT-cx6 (NCT03438396), evaluating tisotumab vedotin administered every three weeks...
Phase II Trial of Tisotumab Vedotin in Advanced Cervical Cancer Provides...
Genmab and Seattle Genetics confirmed their decision to start a Phase II study of tisotumab vedotin in patients with recurrent and/or metastatic cervical cancer....